Kontaktandmed

 

SA TÜ Kliinikum Närvikliinik
L. Puusepa 8, 
51014 TARTU

Tel: +372 731 8519

Vaata kaarti

  1. Braschinsky M., Lüüs SM., Gross-Paju K., Haldre S. The Prevalence of Hereditary Spastic Paraplegia and the Occurrence of SPG4 Mutations in Estonia Neuroepidemiology [Epub ahead of print] 2008, 32 (2): 89-93 article trükimenetlusel 2,203
  2. Jefremov V., Rakitin A., Mahlapuu R., Zilmer K., Bogdanovic N., Zilmer M., Karelson E. 17 beta-oestradiol stimulation of G-proteins in aged and Alzheimer's human brain: Comparison with phytoestrogens Journal of neuroendocrinology 2008, 20 (5): 587-596 article 1.1. 2,588
  3. Ööpik M., Puksa L., Lüüs SM., Kaasik AE., Jakobsen J. Clinical and laboratory-reconfirmed myasthenia gravis: a population-based study European Journal of Neurology 2008, 15 (3): 246-252 article 1.1. 2,58
  4. Krarup LH., Gluud C.,Truelsen T., Pedersen A., Lindahl M., Hansen L., Michelsen S., , Andersen G., Zeng XR., Kõrv J., Oskedra A., Boysen G. The ExStroke Pilot Trial: Rationale, design, and baseline data of a randomized multicenter trial comparing physical training versus usual care after an ischemic stroke Contemporary clinical trials 2008, 29 (3): 410-417 article 1.1. 1,438
  5. Krikmann Ü., Taba P., Lai T., Asser T. Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39) Health & Quality of Life Outcomes 2008, 6 (23): 7 lk. article 1.1.
  6. Sinisalu V. Alkoholist nii ja teisiti Eesti Arsti 2008, 87 (2): 82-83 artikkel 1.3
  7. Kõrv J., Linnamägi Ü., Asser T., Vasar V., Eamets R., Sobocki P. Kui suured on kulutused peaajuhaigustele Eestis? Eesti Arst 2008, 85 (5): 347-355 artikkel 1.3.
  8. Sinisalu V. Meditsiiniuuringud Euroopas - praegune seis ja tulevikustrateegia Eesti Arst 2008, 87 (1): 10-11 artikkel 1.3.
  9. Sinisalu V. Ravijuhendid - kellele, milleks ja mis eesmärgil Eesti Arst 2008, 87 (11): 832-833 artikkel 1.3.
  10. Sinisalu V. Intensiivravi eetilised piirid. Mõtteid konverentsilt Eesti Arst 2008, 87 (12): 974-976 artikkel 1.3.
  11. Vaher A. Gigantne selgroo kaelaosa neurofibroom. Haigusjuhu kirjeldus Eesti Arst 2008, 87 (2): 127-131 artikkel 1.3.
  12. Asser T. Siidemeditsiin-alusteaduste saavutuste rakendamine praktilisse meditsiini Eesti Arst 2008, 87 (3): 169 artikkel 1.3.
  13. Sinisalu V. Muudatused haiglaliikide nõuetes Eesti Arst 2008, 87 (3): 170-172 artikkel 1.3.
  14. Sinisalu V. Elu koos HI-viirusega Eesti Arst 2008, 87 (3): 173-175 artikkel 1.3.
  15. Krikmann Ü., Kalbe I., Lüüs SM., Taba P., Õunapuu A. Neuroborrelioos - puukidega leviv närvisüsteemi bakternakkus Eesti Arst 2008, 87 (3): 214-220 artikkel 1.3.
  16. Sinisalu V. Eesti arstid Rootsis Eesti Arst 2008, 87 (4): 246-249 artikkel 1.3.
  17. Linnamägi Ü., Braschinsky M., Sinisalu V. Aju ja armastus Eesti Arst 2008, 87 (4): 269-273 artikkel 1.3.
  18. Sinisalu V. Kas antidepressandid on toimetud ravimid? Eesti Arst 2008, 87 (4): 288-291 artikkel 1.3.
  19. Kõrv J., Vibo R. Transitoorne isheemiline atakk - insuldi häirekell Eesti Arst 2008, 87 (5): 372-378 artikkel 1.3.
  20. Toomsoo T., Taba P. Treemorid Eesti Arst 2008, 87 (6): 424-430 artikkel 1.3.
  21. Toots I., Sinisalu V. Uriiniinkontinents ja sellega kaasnevad kulud Eesti Arst 2008, 87 (6): 433-439 artikkel 1.3.
  22. Sinisalu V. Statiinid südame-veresoonkonnahaiguste ennetuses ja ravis. Eksperdihinnangud Eesti Arst 2008, 87 (6): 470-472 artikkel 1.3.
  23. Sivisalu V. 20 aastat Eesti Arstide Liidu tegevuse taastamisest Eesti Arst 2008, 87 (6): 474-475 artikkel 1.3.
  24. Sinisalu V. Tervisesüsteemid peavad edaspidi näitama oma tulemuslikku toimimist. WHO Euroopa regiooni ministrite konverents Tallinnas juunis 2008 Eesti Arst 2008, 87 (7-8): 491-494 artikkel 1.3.
  25. Sinisalu V. Insomnia ravi võimalused Eesti Arst 2008, 87 (7-8): 527-532 artikkel 1.3.
  26. Linnamägi Ü. Krooniline valu Eesti Arsti 2008, 87 (1): 53-58 artikkel 1.3.
  27. Sinisalu V. Tervisesüsteemid, tervis ja jõukus Eesti Arsti 2008, 87 (2): 84-86 artikkel 1.3.
  28. Rakitin A., Liik M., Õun A., Haldre S. Remission of seizures in adults with newly diagnosed epilepsy: 12 years of followc up European journal of neurology 2008, 15 (Supplement: Suppl. 3): 85-85 meeting abstract 5.1. 2,58
  29. Vibo R., Kõrv J., Roose M. Trends in long-term outcome of first-ever stroke in Tartu, Estonia. A population-based study from 1991 to 2003 European journal of neurology 2008, 15 (Supplement: Suppl. 3 ): Pages: 247-248 meeting abstract 5.1. 2,58
  30. Rannikmäe K., Braschinsky M., Lüüs SM., Krikmann Ü., Gross-Paju K., Haldre S. Health-related quality of life in patients with hereditary spastic paraplegia in Estonia European journal of neurology 2008, 15 (Supplement: Suppl. 3 ): 360-360 meeting abstract 5.1.
  31. Haldre S. Epilepsia ravi - millal alustada, kuidas juhtida ning millal lõpetada Lege Artis 2008, (1(69)): 5-9 artikkel 6.3.
  32. Braschinsky M. Pearinglus ja tasakaaluhäired: tsentraalsed põhjused Lege Artis 2008, (8): 5-7 artikkel 6.3.
  33. Taba P. Parkinsoni tõbi sai ravijuhendi Meditsiiniuudised 2008, (13(135)): 18 artikkel 6.3.
  34. Linnamägi Ü. Kommentaar artiklile: Alzheimeri tõve ravisihtmärkidele keskendunud neli kliinilist uuringut : ülevaade juulis toimunud Alzheimeri Assotsiatsiooni konverentsil avaldatud materjalidest Lege Artis 2008, (8): 32-34 kommentaar 6.3.
  1. Autor Pealkiri Ilmumisallikas Publikats. tüüp Liigitus Ajakirja IF06 Vibo R., Kõrv J., Roose M., Kampus P., Muda P., Zilmer K., Zilmer M. Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome Free radical research 2007, 41 (3): 282-287 article 1.1. 2.536
  2. Vibo R., Kõrv J., Roose M. One-year outcome after first-ever stroke according to stroke subtype, severity, risk factors and pre-stroke treatment. A population-based study from Tartu, Estonia European Journal of Neurology 2007, 14 (4): 435-439 article 1.1. 2.437
  3. Kisand KE., Prükk T., Kisand KV., Lüüs SM., Kalbe I., Uibo R. Propensity to excessive proinflammatory response in chronic Lyme borreliosis APMIS 2007, 115 (2): 134-141 article 1.1. 1.875
  4. Sikk K., Taba P., Haldre S., Bergquist J., Nyholm D., Zjablov G., Asser T., Aquilonius SM. Irreversible motor impairment in young addicts - ephedrone, manganism or both? Acta Neurologica Scandinavica 2007, 115 (6): 385-389 article 1.1. 1.833
  5. Vibo R., Kõrv J., Roose M. The Third Stroke Registry in Tartu, Estonia, from 2001 to 2003 Acta neurologica Scandinavica 2007, 116 (1): 31-36 article 1.1. 1.833
  6. Macht M., Gerlicha C., Ellgring H., Taba P., Krikmann Ü., Kanarik E. Patient education in Parkinson's disease: Formative evaluation of a standardized programme in seven European countries Patient Education and Counseling 2007, 65 (2): 245-252 article 1.1. 1.778
  7. Tomberg T., Toomela A., Ennok M., Tikk A. Changes in coping strategies, social support, optimism and health-related quality of life following traumatic brain injury: A longitudinal study Brain Injury 2007, 21 (5): 479-488 article 1.1. 1.182
  8. Laugesaar R, Kolk A, Tomberg T, Metsvaht T, Lintrop M, Varendi H, Talvik T .Acutelyand retrospectively diagnosed perinatal Stroke: a population based study Stroke 2007; 38(8):2234-2240 article 1.1
  9. Macht M., Pasqualini MS.,Taba P. Cognitive-behavioral strategies for Parkinson's disease: A report of three cases Journal of clinical psychology in medical settings 2007, 14 (2): 165-176 article 1.1.
  10. Areda T. Kassilõhna tekitatud ärevuse mehhanismide käitumuslik ja neurogeneetiline uurimus närilistel. Doktoriväitekirja kokkuvõte Eesti Arst 2007, 86 (1): 27-30 artikkel 1.3.
  11. Linnamägi Ü., Ainjärv H. Õnnetunne ja immuunsüsteem Eesti Arst 2007, 86 (1): 31-34 artikkel 1.3.
  12. Puksa L., Kaasik AE Lihasekrambid Eesti Arst 2007, 86 (1): 49-54 artikkel 1.3.
  13. Sinisalu V. Venoosne trombemboolia Eesti Arst 2007, 86 (10): 725-728 artikkel 1.3.
  14. Braschinsky M., Vibo R., Rallmann K., Asser A., Tomberg T. Aju venoossete siinuste tromboos Eesti Arst 2007, 86 (12): 897-902 artikkel 1.3.
  15. Vähi M., Kirsimägi Ü., Braschinsky M. Alzheimeri tõve ravi memantiiniga Eestis: farmakoökonoomiline hindamine Eesti Arst 2007, 86 (2): 94-99 artikkel 1.3.
  16. Linnamägi Ü., Braschinsky M., Tikk A. Fibromüalgia Eesti Arst 2007, 86 (3): 201-206 artikkel 1.3.
  17. Braschinsky M., Areda T., Linnamägi Ü. APRILL! Tartu Ülikooli närvikliinikus töötamine suurendab kaksikute sündimise riski Eesti Arst 2007, 86 (4): 235-238 artikkel 1.3.
  18. Brin V., Braschinsky M., Haldre S. Tugeva äkkpeavalu diferentsiaaldiagnoos Eesti Arst 2007, 86 (4): 262-265 artikkel 1.3.
  19. Krikmann Ü., Kalbe I., Lüüs SM., Taba P., Õunapuu A. Puukentsefaliit - sage närvisüsteeemi viirushaigus Eesti Arst 2007, 86 (4): 273-276 artikkel 1.3.
  20. Sinisalu V. Puukentsefaliit - kogu Euroopas levinud haigus Eesti Arst 2007, 86 (5): 305-306 artikkel 1.3.
  21. Heinola E., Sinisalu V. Mittespetsiifiline püogeenne spondüliit Eesti arst 2007, 86 (7): 485-492 artikkel 1.3.
  22. Asser T. 375 aastat Tartu Ülikooli arstiteaduskonda Eesti Arst 2007, 86 (9): 607-609 artikkel 1.3.
  23. Tomberg T Uued rakendusalad radioloogias. Eesti Arst 2007;86(6): 379-380 artikkel 1.3
  24. Veldi M., Sinisalu V. Unehäired ja liiklusohutus Unehäired ja liiklusohutus: ajakirja Eesti Arst lisaväljaanne 2007, 86 (12): [17] lk. artikkel 1.3.
  25. Brilene, Tatjana; Hedman, Anu; Kirss, Anne; Kullamaa, Anneli; Kõrv, Janika; Oselin, Kersti; Otter, Kersti; Ristimäe, Tiina; Visnapuu, Piret; Peet, Kertu Neuroloogiliste haiguste farmakoteraapia raseduse ajal. Rasedate farmakoteraapia. Tallinn: Medicina(2007) Lk 114 - 125 Peatükk raamatus 2.2
  26. Asser T, Linnamägi Ü, Kaasik A.E., Tikk A, Tomberg T. Närvikliinik. Tartu Ülikooli Arstiteaduskond 1982-2007. Tartu; Tartu Ülikooli Kirjastus. Toim K. Kalling Lk 308-328. Peatükk raamatus 2.2
  27. Linnamägi Ü., Vahter L., Jaanson K., Tomberg T., Lüüs S.M., Gross-Paju K., Kreis A., Toomsoo T. Dementsuse Eesti ravi-, tegevus- ja diagnostikajuhend http://www.haigekassa.ee/ raviasutusele/ ravijuhendid 2007, 43 lk. ravijuhis ravijuhis
  28. Gross-Paju K., Vahter L., Tomberg T., Talvik T., Haldre S., Lüüs S-M., Kalbe I. Sclerosis multiplex'i Eesti ravijuhend http://www.haigekassa.ee/raviasutusele/ravijuhendid/ andmebaas/tunnustatud   2007, 74 lk. ravijuhis ravijuhis
  29. Kõrv J. Insult - kas halvasti ravitud kõrgvererõhu tagajärg? Hüpertensioon: ajakirja Lege Artis lisaväljaanne 2007, (11(68)): 17-20 artikkel 6.3.
  30. Braschinsky M. Pearinglus - fookuses vestibulaarne düsfunktsioon Lege Artis 2007, (7(64)): 15-18 artikkel 6.3.
  31. Krikmann Ü. Närvisüsteemi kahjustusega seotud paraneoplastilised sündroomid Lege Artis 2007, (7(64)): 5-7 artikkel 6.3.
  32. Haldre S. Peavalu naistel - kas ainult ettekääne Naise Tervis: ajakirja Lege Artis lisaväljaanne 2007, (lisa6(63)): 27-28 artikkel 6.3.
  33. Kõrv J. Framinghami uuringu tulemused võrreldes Eesti olukorraga Lege Artis 2007, (3(60)): 35-36 kommentaar 6.3.
  34. Linnamägi Ü. Statiinid ja Alzheimeri tõbi Lege Artis 2007, (8(65)): 29-30 kommentaar 6.3.

Sööt A, Tomberg T, Talvik T. Magnetic resonance imaging (MRT) in diplegic cerebral palsy. Eur J Paed Neurol 2007 (11)34-35 Abstract 5.2

  1. Vibo R, Kõrv J, Roose M. One-year outcome after first-ever stroke according to stroke subtype, severity, risk factors and pre-stroke treatment. A population-based study from Tartu, Estonia.  European Journal of Neurology 2007;14:435-439.
  2. Vibo R, Kõrv J, Roose M, Kampus P, Muda P, Zilmer K, Zilmer M. Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome.  Free Radical Research 2007;41:282-287.
  3. Vibo R, Kõrv J, Roose M. The Third Stroke Registry in Tartu, Estonia from 2001 to 2003. Acta Neurologica Scandinavica 2007. In press. Published online on 5th February, 2007.

CC, A1

  1. Areda T, Koks S, Philips MA, Vasar E, Karis A, Asser T. Alterations in opioid system of the rat brain after cat odor exposure. Neurosci Lett. 2005 Mar 29;377(2):136-9.

  2. Vibo R, Kõrv J, Roose M. The Third Stroke Registry in Tartu, Estonia: decline of the incidence and case fatality of stroke since 1991. Stroke 2005 36: 2544 - 2548.

  3. Tomberg T., Toomela A.,. Pulver A, Tikk A. – Coping strategies, social support, life orientation and health-related quality of life following traumatic brain injury. Brain Injury 2005; 19(14):1181–1190.

  4. Sööt A., Hämarik M., Tomberg T., Talvik T.. Magnetic resonance imaging in mild forms of diplegic cerebral palsy. Eur J Paed Neurol 2005;9(3–4):267–268

  5. Orr S, Alexandre E, Clark BJ, Gray N, Helin H, Ravid R, Read M, Richert L, Roosipuu R, Jonsson-Rylander AC, Syring C, Teesalu T, Thasler WE, Trafford J, Van Der Valk J, Weiss TS, Womack C, Ylikomi T. Fourth meeting of the European Network of Research Tissue Banks - future strategy to increase collaborations in the supply of human tissue for biomedical research. Cell Tissue Bank. 2005;6(2):131-8.

  6. Gronholm M, Teesalu T, Tyynela J, Piltti K, Bohling T, Wartiovaara K, Vaheri A, Carpen O.  Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.  Mol Cell Neurosci. 2005 Apr;28(4):683-93. 1.3. 

  7. Eelmäe P., Ankru K., Arvi M., Eelmäe J., Asser T.  The effect of postsurgical physiotherapy for unilateral cervical radiculopathy patients functional state. In: 3rd World Congress of the International Society of Physical an Rehabilitation Medicine. Bologna: Monduzzi Editore, 2005. pp. 423-426 (ISI Proceedings)

  8. Taba P; Asser T. Epidemiology of Parkinson’s disease. Reviews in Clinical Gerontology 2005; 14: 1-18.

  1. Teesalu T, Kulla A, Simisker A, Siren V, Lawrence DA, Asser T, Vaheri A.   Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system.Thromb Haemost. 2004 Aug;92(2):358-68.

  2.  Asser T, Linnamagi Ü. Telemedicine in Baltic sea region: Experiences of Tartu University. CMJ 2004, 45 (5): 523-5.

  3. Kohler F, Fotuhi P, Schierbaum C, Asser T. Telemedicine/e-health in Estonia, Deutsche Medizinische Wochenschrift, 2004 129: S17-S20 Suppl. 1 APR 30

  4.  Vibo R, Kõrv J, Roose M, Haldre S. First year results of the third stroke registry in Tartu, Estonia. Cerebrovasc Dis 2004;18 (3),  227-31.

  5.  Pendlebury S, Rothwell PM, Algra A, Ariesen MJ, Bakac G, Czlonkowska A, Dachenhausen A, Krespi Y, Kõrv J, Krolikowski K, Kulesh S, Michel P, Tomassen L, Bogousslavsky J, Brainin M. Underfunding of Stroke Research: A Europe-Wide Problem. Stroke 2004; 35: 2368 - 71.

  6. Toomela A, Pulver A, Tomberg T, A. Orasson, Tikk A, Asser T. Possible interpretation of subjective complaints in patients with spontaneous subarachnoid haemorrhage. J Rehabil Med 2004; 36:63-9.

  7.  Paasuke M, Ereline J, Gapeyeva H, Taba P. Leg-extension strength and chair-rise performance in elderly women with Parkinson's disease. J Aging Phys Activity 2004. 12 (4): 511-24.

  1. Toomela A, Pulver A, Tomberg T, Orasson A, Tikk A, Asser T. Possible interpretation of subjective complaints in patients with spontaneous subarachnoid haemorrhage. J Rehabil Med 2003; 35:1–7(in press) (submitted May 22, 2002).
  2. Gronholm M, Vossebein L, Carlson CR, Kuja-Panula J, Teesalu T, Alfthan K, Vaheri A, Rauvala H, Herberg FW, Tasken K, Carpen O. Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A. J Biol Chem. Accepted 2003 Aug 1.
  3. Chen RW, Aalto Y, Teesalu T, Durst M, Knuutila S, Aaltonen LM, Vaheri A. Establishment and characterisation of human papillomavirus type 16 DNA immortalised human tonsillar epithelial cell lines. Eur J Cancer 2003 Mar;39(5):698–707.
  4. Kulla A, Burkhardt K, Meyer-Puttlitz B, Teesalu T, Asser T, Wiestler OD, Becker AJ. >Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature. Acta Neuropathol (Berl). 2003 Apr;105(4):328–32. Epub 2003 Feb 14.
  5. Taba P, Asser T. Incidence of Parkinson’s disease in Estonia. Neuroepidemiology 2003; 22: 41–45.
  6. Rekand T, Kõrv J, Farbu E, Roose M, Gilhus N-E, Langeland N, Aarli JA. Life style and late effects after poliomyelitis. A risk factor study of two populations. Acta Neurologica Scandinavica, in press October 2003.
  7. Rekand T, Kõrv J, Farbu E, Roose M, Gilhus NE, Langeland N, Aarli JA. Long term outcome after poliomyelitis in different health and social conditions. Journal of Epidemiology and Community Health 2003;57:368–72. (Accepted 16 Aug 2002)
  8. Õun A, Haldre S, Mägi M. Incidence of adult epilepsy in Estonia. Acta Neurologica Scandinavica 2003:107: 1–7. (accepted Nov 14 2002).
  9. Õun A, Haldre S, Mägi M. Prevalence of adult epilepsy in Estonia. Epilepsy Research 2003; 52:233–42. (accepted Oct 11 2002).
  10. Puksa L, Stalberg E, Falck Björn. >Occurrence of A waves in F wave studies of Healthy nerves. Muscle & Nerve. (submitted November 2002, accepted July 2003).
  11. Puksa L, Stahlberg E, Falck B. Reference values of F wave parameters  in Healthy subjects. Clinical Neuropysiology 2003;114:1079–90 (accepted 2002).
  1. Taba P, Asser T. Prevalence of Parkionson disease in Estonia. Acta Neurologica Scandinavica 2002, 106(5), 276–81.

  2. Pääsuke M, Mõttus K, Ereline J, Gapeyeva H, Taba P. Lower limb performance in older female patients with Parkinson’s disease. Aging Clinical and Experimental Research 2002 14(3): 185–91.

  3. Teesalu T, Kulla A, Asser T, Koskiniemi M, Vaheri A. Tissue plasminogen activator as a key effector in neurobiology and neuropathology. Biochem Soc Trans 2002 Apr;30(2):183–9.

  4. Rätsep T, Eelmäe J, Asser T. Routine utilization of the transient hyperaemic response test after aneurysmal subarachnoid haemorrhage. Acta Neurochirurgica. Intracranial pressure and brain biochemical monitoring. Eds: Czosnyka M, 2002;(Suppl) 81:121–4.

  5. Leibur E, Borstlap W, Asser T, Stoelinga PW. >Cranio-osteoplasty and Fronto-orbital Advancement for Apert Syndrome: a case Report. Stomatologija 2002; (Suppl 1)4:, 74–5.

  6. Kulla A, Teesalu T, Simisker A, Asser T. Molecular mechanisms of invasion of astrocytic tumours. Review. In: Neuropathology — back to the roots. Ed: Bohl J. Shaker. Aachen: Verlag; 2002.
  1. Rätsep T., Asser T. Cerebral hemodynamic impairmane after aneurysmal subarachnoid hemorrhaga as evaluated by transcranial doppler ultrasound: relations to delayed cerebral ischemia and clinical outcome. J Neurosurgery, 2001 95, 393-401.

  2. Liigant A., Haldre S., Õun A., Linnamägi Ü., Saar A., Asser T. Seizure Disorders in Patients with Intracranial Tumor. European Neurology. 2001;45-:46-51

  3. Tomberg T., A. Orasson, Ü. Linnamägi, A. Toomela, A. Pulver, T. Asser - Coping strategies in patients following subarachnoid haemorrhage. Acta Neurol Scand 2001 (in press).

  4. Tõnu Rätsep, Toomas Asser: Prognostic Value and Determinants of Early versus Late Cerebral Autoregulatory Impairment as Examined by Transient Hyperaemic Response Tests after Aneurysmal Subarachnoid Haemorrhage. Journal of Neurology, Neurosurgery & Psychiatry, accepted.2001

  5. Liigant A., A. Kulla, Ü. Linnamägi, T. Asser, A-E. Kaasik. Survival of patients with primary CNS tumours in Estonia. Eur J Cancer. In Press.2001

  6. Herodes M., A. Õun, S. Haldre, A.-E. Kaasik. Epilepsy in Estonia: a quality of life study. Epilepsia 2001;42(8) In press.

  7. Kolk, A. Beilmann, T. Tomberg, A. Napa, T. Talvik – Neurocognitive development of children with congenital unilateral brain lesion and epilepsy. Brain and Development 2001;23(2):88-96.

  1. Tõnu Rätsep, Talvi Kallasmaa, Aleksander Pulver, Katrin Gross-Paju: Personality as a predictor of coping efforts in patients with multiple sclerosis. Multiple Sclerosis 2000, 6 (6), 397-402.

  2. Marju Rätsepp, Õun A., Haldre S., Kaasik A.-E. Felt stigma and impact of epilepsy on employment status among Estonian people: exploratory study, Seizure 2000, 9, 394-401

  3. Tõnu Rätsep, Jaan Eelmäe, Toomas Asser: Routine utilization of the transient hyperaemic response test after aneurysmal subarachnoid haemorrhage. Acta Neurochirurgica, accepted,ICP XI. J Pickard, M. Scoznica. (eds), Acta Neurochirurgica by Springer Verlag, 2000

  4. Aive Liigant, T. Asser, A. Kulla, A-E. Kaasik. Epidemiologuy of Primary central nervous system tumors in Estonia. Neuroepidemiology 2000, 19: 300-311.

  5. Kulla A., Liigant A., Piirsoo A., Rippin G., Asser T. Tenascin expression and cells of monocyte lineage: relationship in human gliomas. Modern Pathology Vol. 13(1), 2000, pp. 56-67.

  6. Linnamägi Ü., Asser T. Dementsussündroom ja selle põhjused. Tartu Ülikooli Kirjastus .148 lk

  1. Kõrv J, Roose M, Haldre S, Kaasik A.-E. Registry of first-ever stroke in Tartu, Estonia, 1991 through 1993: outcome of stroke. Acta Neurol Scand 1999;99:175-81
  2. A. Toomela, T. Tomberg, A. Orasson, A. Tikk, M. Nõmm – Paradoxical fascilitation of a free recall of nonwords in persons with traumatic brain injury. Brain and Cognition 1999;39:187-201.
  3. Gross-Paju K., Ööpik M., Lüüs S.-M., Kalbe I., Kaasik A.-E. The risk of motor neurone disease and multiple sclerosis is different in Estonians and Russians. Data from South Estonia. European Journal of Neurology, 1999, 6: 187-193
  4. Lanzino G., Kassel N.F., Dorsch N.W.C., et al (Asser T.). Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand and South Africa. Journal of Neurosurgery 1999; 90, 1011-1017
  1. Kõrv J. Incidence, case-fatality and outcome of stroke. Dissertationes Medicinae Universitatis Tartuensis, 33. Tartu University Press, 1998.
    Linnamägi Ü. Changes in local cerebral blood flow amd lipid peroxidation following lead exposure in expement. Dissertationes Medicinae Universitatis Tartuensis, 34. Tartu University Press, 1998.
  2. Kõiv L. Reaction of the sympatho-adrenal and hypothalamo-pituitary adrenocortical system in the acute stage of head injury. Dissertationes Medicinae Universitatis Tartuensis, 46. Tartu University Press, 1998.
  3. Gross-Paju K, Ööpik M, Lüüs M, Kalbe I, Puksa L, Lepik T, Kaasik A.-E. Motor neurone disease in South Estonia. Diagnosis and incidence rate. Acta Neurol Scand, 1998, 98, p. 22-28.
  4. Kõrv J, Roose M, Haldre S, Kaasik A.-E. Registry of first-ever stroke in Tartu, Estonia, 1991 through 1993: outcome of stroke. Acta Neurologica Scandinavica
  5. Kõrv J., Roose M., Kaasik A.-E. Stroke epidemiology. in: D.C. Bergen et al. ed. "Progress in Neurology Update II" New Delhi, B.I. Churchill Livingstone Pvt Ltd, 1998, 17-26.
  6. Gross-Paju K. The risk of motor neurone disease and multiple sclerosis is different in Estonians and Russians. Data from South Estonia. Eur J Neurol
  7. Bachmann T., Asser T., Sarv M., Taba P., Lausvee E., Põder E., Kahusk N., Reitsnik T. The speed of elementary visual recognition operation in Parkinson’s disease as measured by the mutual masking method. J. of Clinical and Experimental Neuropsychology, 1998, 20, 1, 118-134
  8. The International 311C90 Long-term Study Group (incl. A.-E. Kaasik). The long term tolerability and efficacy of oral Zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. Headache, 1998, 38, 3, 173-182
  9. Heinsoo M., Eelmäe J., Kuklane M., Tikk A., Asser T. The possible role of CSS hydrodynamic parameters in management of SAH patients. Acta Neurochirurgica (Springer Verlag), 1998 : Suppl 71, 13-15. ,
    1. Kõrv J., Roose M., Kaasik A.-E. Stroke registry of Tartu, Estonia, from 1991 through 1993. Cerebrovasc. Dis.,1997, 7, 154-162

 

    1. Kõiv L., Merisalu E., Zilmer K., Tomberg T., Kaasik A.-E. Changes of Sympatho-adrenal and hypothalamo-pituitary-adrenocortical system in patients with head injury. Acta Neurol. Scand.,1997, 96, 52-8

 

    1. Linnamägi Ü., Zilmer K., Zilmer M., Kaasik A.-E. Lead-induced excessive lipid peroxidation and changes in local cerebral blood flow in rabbit brain. Europ. J. Neurol.,1997, 4, 390-6

 

    1. Linnamägi Ü., Asser T., Kaasik A.-E. Närvisüsteemi kasvajad. Kogumikus: Pahaloomuliste kasvajate diagnostika ja ravijuhised, 1997, 147-156

 

    1. Kõrv, J., Roose, M., Kaasik, A.-E. Changed incidence and case-fatality rates of first-ever stroke between 1970 and 1993 in Tartu, Estonia. Stroke 1996, 27, 199-203

 

    1. Tomberg, T., Rink, U., Pikkoja, E., Tikk, A. Computerized Tomographyand Prognosis in Paediatric Head Injury. Acta Neurochir (Wien), 1996, 138,543-548

 

    1. Talvik T., Mägi M. Pediatric neurology in Estonia. Brain and Development,1996, 18, 336-337.

 

    1. T.Talvik, S.Haldre, A.Sööt, M.Hämarik, A.Piirsoo, A.-V.Mikelsaar. Creatine kinase isoenzyme BB concentrations in cerebrospinal fluid in asphyxiated preterm neonates. Acta Paediatr 84: 1183-7, 1995.

 

    1. Ü.Linnamägi. A.E Kaasik. Changes of LCBF concomitant to lead exposure in adult rabbits. Acta Neurologica Scandinavica 92, 6, 491-496, 1995.

 

    1. T.Tomberg, U.Rink, E.Pikkoja, A.Tikk. Computerized Tomography and Prognosis in Paediatric Head Injury. Acta Neurochirurgica

 

    1. Gross, K., Kokk, A., Kaasik, A.-E. Prevalence of MS in South Estonia. Evidence of a new border of the Fennoscandian focus. Acta Neurol. Scand., 1993,88,241-246

 

    1. Gross, K., Tomberg, T., Kokk, A., Kaasik, A.-E. Prognosis in multiple sclerosis. Some correlations between clinical findings and CT. Zh. Nevropatol. i Psihiatrii. 1993, 3, 42-44 (Russ.)

 

    1. Kaasik A.-E. Koiv L. et al. The status of sympatic-adrenal and hypothalamic-hypophyseal-adrenocortic system in respect with the severity of cerabral trauma. Vopr. Neirohir. 1994, 1, 26-29 (Russ.).

 

    1. Ikeda, H., Asser, T., Yoshimoto, T. Proliferation and differentiation of transplanted embryonic diencephalon in the brain of adults rats. Restorative Neurology and Neuroscience, 1994, 7, 79-87.

 

    1. J.Eelmäe, M.Kuklane, M.Heinsoo, A.Tikk. CSF Pressure Parameters and Ventricular Size Dynamics in Aneurysmatic SAH and Head Injured Patients. In:Intracranial Pressure IX. Eds: N.Nagay, K.Kamiya and S.Ishii. Springer Verlag, Tokyo, 1994, pp.544-548.